(HealthDay)—Patients with a CYP2C19 loss-of-function allele have increased risk of major adverse cardiovascular events (MACE) with clopidogrel versus alternative antiplatelet therapy after percutaneous coronary intervention ...
Nov 3, 2017
0
0
Sporting events often leave people on the edge of their seats, but what does all that excitement do to their hearts? A new study suggests that both the thrill of victory and the agony of defeat can have a substantial effect ...
Oct 5, 2017
0
135
Ibuprofen is associated with increased blood pressure and hypertension compared to celecoxib in patients with osteoarthritis or rheumatoid arthritis and increased risk of cardiovascular disease, according to late-breaking ...
Aug 28, 2017
0
0
A major international study has found that the combination of two drugs - rivaroxaban and aspirin—is superior to aspirin alone in preventing further heart complications in people with vascular disease.
Aug 28, 2017
0
2
An updated analysis of the low-density lipoprotein cholesterol (LDL-C) lowering drugs, proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors, finds they are not cost-effective at current prices and that even greater ...
Aug 22, 2017
0
0
(HealthDay)—Five years after coronary-artery bypass grafting (CABG) surgery, patients whose operation was performed with cardiopulmonary bypass (on pump) lived longer than those whose surgeons performed the procedure without ...
Aug 18, 2017
0
0
(HealthDay)—For patients with an adverse reaction to a statin, continued statin prescriptions are associated with lower incidence of cardiovascular events and death, according to a study published online July 25 in the ...
Jul 25, 2017
0
0
Statins are known to reduce the risk of death and cardiovascular events for people who are at high risk; however, as many as 75 percent of patients discontinue statin therapy within two years, often after reporting an adverse ...
Jul 24, 2017
0
0
(HealthDay)—For asymptomatic patients with type 2 diabetes, the addition of coronary computed tomography angiography (CCTA)-detected obstructive coronary artery disease (CAD) improves prediction of major adverse cardiovascular ...
Jul 10, 2017
0
0
(HealthDay)—For acute coronary syndrome (ACS) patients undergoing percutaneous coronary intervention (PCI) and receiving clopidogrel, prasugrel, or ticagrelor, ischemic outcome does not differ by gender, according to a ...
May 4, 2017
0
0
